Clinical Trials Directory

Trials / Completed

CompletedNCT05154513

Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV

Status
Completed
Phase
Study type
Observational
Enrollment
163 (actual)
Sponsor
International Maternal Pediatric Adolescent AIDS Clinical Trials Group · Network
Sex
All
Age
Healthy volunteers
Not accepted

Summary

IMPAACT 2028 is an observational prospective study to characterize a cohort of early treated children who may participate in future research related to HIV remission or cure. Up to approximately 250 participants will be in the study for approximately seven years. No intervention is provided in the study.

Detailed description

This is an observational prospective cohort study characterizing and establishing a biorepository of early treated children who may participate in future research related to HIV remission or cure. Early treatment is defined as treatment with at least three ARV agents from at least two classes of ART initiated within 12 weeks of birth. Within the overall study population, for descriptive and analysis purposes, children who initiated treatment within 48 hours of birth will be classified as having received very early treatment. A subset of children will have received bNAbs as part of their treatment regimens. Up to approximately 250 children living with HIV who received early treatment in IMPAACT network studies or other research studies sponsored by the US National Institutes of Health (NIH) will be enrolled and followed semi-annually for up to seven years. Clinical, virologic, and immunologic evaluations will be performed semi-annually at each study visit, and specimens will be collected for the study's biorepository for future investigations.

Conditions

Interventions

TypeNameDescription
OTHERCohort 1No intervention provided in this study

Timeline

Start date
2022-02-02
Primary completion
2025-07-30
Completion
2025-07-30
First posted
2021-12-13
Last updated
2026-01-13

Locations

28 sites across 11 countries: United States, Botswana, Brazil, Haiti, Kenya, Malawi, South Africa, Tanzania, Thailand, Uganda, Zimbabwe

Source: ClinicalTrials.gov record NCT05154513. Inclusion in this directory is not an endorsement.